Penserra Capital Management LLC now owns 1,959 shares of the …
BMY
The institutional investor owned 34,789 shares of the biopharmaceutical …
BMY
Wall Street renowned brokerages following Bristol-Myers Squibb Company (NYSE:BMY) have now given a mean price target of $66.272 on its stock. After accomplishing a methodical study, the analysts have specified a …
BMY
Bristol-Myers Squibb was off to what seemed like it was going to be a great day in the market today. At the opening bell, the stock was …
BMY
Vetr lowered Bristol-Myers Squibb Company from a "strong-buy" rating …
BMY
Another lazy day for stocks. The major indices edged higher and lower …
BMY
Yesterday Bristol-Myers Squibb Co (NYSE:BMY) traded -0.58% lower at $56.22. The company’s 50-day …
Zacks Investment Research
Vanguard Group Inc. now owns 109,554,831 shares of the biopharmaceutical company's stock worth $8,057,758,000 after buying an additional 3,595,648 shares in the last quarter. BlackRock Institutional Trust …
BMY